Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 97051-97100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04428372
MAnnitol for Blood Pressure Stability in HemoDialysis (MAP-HD)
PHASE2/PHASE3
Recruiting
30 participants
Started: Apr 6, 2021 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT04052828
Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)
NA
Recruiting
10 participants
Started: Apr 5, 2021 · Completed: Jun 30, 2028
1 condition
1 sponsor
1 location
NCT04616781
Ketone Ester Intervention in Alcohol Use Disorder
PHASE2/PHASE3
Recruiting
20 participants
Started: Apr 5, 2021 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT05212129
Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
NA
Recruiting
90 participants
Started: Apr 5, 2021 · Completed: Dec 31, 2026
5 conditions
3 sponsors
1 location
NCT06799728
Uterus Transplantation: Acceptability of the Procedure in Eligible Patients
N/A
Active, not recruiting
150 participants
Started: Apr 5, 2021 · Completed: Apr 5, 2026
2 conditions
1 sponsor
1 location
NCT06682377
Radiofrequency Ablation Using Combined RF Energy Delivery Mode and Octopus Electrodes for Hepatocellular Carcinoma
NA
Active, not recruiting
159 participants
Started: Apr 5, 2021 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT04728893
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
PHASE2
Recruiting
490 participants
Started: Apr 5, 2021 · Completed: Mar 19, 2027
4 conditions
1 sponsor
122 locations
NCT04816604
Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
PHASE2
Active, not recruiting
74 participants
Started: Apr 5, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
31 locations
NCT05061680
Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)
NA
Recruiting
600 participants
Started: Apr 5, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
2 locations
NCT06170541
CORE-COMPARE Pilot Study
NA
Recruiting
140 participants
Started: Apr 5, 2021 · Completed: Apr 5, 2027
1 condition
2 sponsors
1 location
NCT04826523
Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)
N/A
Recruiting
600 participants
Started: Apr 5, 2021 · Completed: Nov 30, 2025
1 condition
1 sponsor
10 locations
NCT04379115
Optimization of NIBS for Treatment of Addiction
NA
Recruiting
126 participants
Started: Apr 4, 2021 · Completed: Oct 31, 2027
2 conditions
2 sponsors
2 locations
NCT04831125
Conduction System Pacing International Registry (CONSPIRE)
N/A
Active, not recruiting
383 participants
Started: Apr 4, 2021 · Completed: Feb 28, 2026
2 conditions
2 sponsors
8 locations
NCT06442852
Study on the Relationship Between Peripheral Blood miRNA and Risk and Severity of Alzheimer's Disease
N/A
Recruiting
500 participants
Started: Apr 3, 2021 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
NCT04777435
Therapeutic Orientation Test in Thrombotic Microangiopathy
NA
Recruiting
100 participants
Started: Apr 3, 2021 · Completed: Apr 3, 2027
1 condition
1 sponsor
20 locations
NCT04818177
Immunoglobulin G Therapy Dose Optimization
N/A
Recruiting
40 participants
Started: Apr 2, 2021 · Completed: Dec 1, 2025
2 conditions
1 sponsor
1 location
NCT04749446
Study on Clinical Features and Outcomes of Breast Sarcoma
N/A
Recruiting
300 participants
Started: Apr 2, 2021 · Completed: Dec 1, 2025
1 condition
1 sponsor
14 locations
NCT05066763
Parkinson's Foundation Surveys
N/A
Recruiting
1,000,000 participants
Started: Apr 2, 2021 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT04511078
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
PHASE2
Recruiting
25 participants
Started: Apr 2, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT04904146
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
N/A
Recruiting
120 participants
Started: Apr 2, 2021 · Completed: Apr 30, 2027
2 conditions
1 sponsor
1 location
NCT04774419
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery
PHASE2
Recruiting
62 participants
Started: Apr 2, 2021 · Completed: Feb 28, 2026
1 condition
2 sponsors
7 locations
NCT04843527
Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People With T2 Diabetes
NA
Active, not recruiting
350 participants
Started: Apr 2, 2021 · Completed: Jun 30, 2025
1 condition
1 sponsor
4 locations
NCT04838444
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
PHASE3
Active, not recruiting
363 participants
Started: Apr 2, 2021 · Completed: May 31, 2031
1 condition
1 sponsor
10 locations
NCT04675294
Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)
PHASE2
Active, not recruiting
189 participants
Started: Apr 2, 2021 · Completed: Jun 30, 2026
2 conditions
2 sponsors
53 locations
NCT04851288
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
PHASE2
Recruiting
112 participants
Started: Apr 2, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT04550676
High-Intensity Exercise to Attenuate Limitations and Train Habits in Older Adults With HIV
NA
Active, not recruiting
118 participants
Started: Apr 2, 2021 · Completed: Nov 24, 2025
3 conditions
3 sponsors
2 locations
NCT05222594
Computational Neuroscience of Language Processing in the Human Brain
NA
Recruiting
40 participants
Started: Apr 2, 2021 · Completed: Mar 31, 2026
2 conditions
2 sponsors
1 location
NCT05717998
Imaging and Blood-Based Biomarkers for the Evaluation of Early Signs of Myocardial Injury After Thoracic Radiation Therapy
N/A
Recruiting
40 participants
Started: Apr 2, 2021 · Completed: Jun 18, 2026
3 conditions
1 sponsor
1 location
NCT05645679
Efficacy and Safety of HYbrid Argon Plasma Coagulation Technique in Patients With Barrett's Esophagus-Related Dysplasia
N/A
Recruiting
50 participants
Started: Apr 2, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04836156
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer Patients
PHASE1/PHASE2
Recruiting
46 participants
Started: Apr 2, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04806919
Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone
PHASE3
Recruiting
242 participants
Started: Apr 2, 2021 · Completed: Jan 1, 2025
3 conditions
1 sponsor
2 locations
NCT04722250
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
NA
Active, not recruiting
1,103 participants
Started: Apr 2, 2021 · Completed: Dec 31, 2027
3 conditions
1 sponsor
92 locations
NCT05261802
AVANCE-Houston FRAMEWorks Program Evaluation
NA
Active, not recruiting
1,682 participants
Started: Apr 1, 2021 · Completed: Aug 15, 2025
1 condition
2 sponsors
1 location
NCT04939805
CRP Apheresis in STEMI
NA
Recruiting
202 participants
Started: Apr 1, 2021 · Completed: Aug 31, 2025
4 conditions
1 sponsor
5 locations
NCT04748874
Immediate Versus Postponed Single Blastocyst Transfer in mNC-FET
NA
Active, not recruiting
464 participants
Started: Apr 1, 2021 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT04101838
B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults
PHASE4
Recruiting
50 participants
Started: Apr 1, 2021 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05132881
Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers
NA
Active, not recruiting
90 participants
Started: Apr 1, 2021 · Completed: Nov 20, 2025
4 conditions
1 sponsor
1 location
NCT04834869
COVID-19 Vaccines Safety Tracking (CoVaST)
N/A
Recruiting
30,000 participants
Started: Apr 1, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
14 locations
NCT04682158
Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
PHASE2
Recruiting
106 participants
Started: Apr 1, 2021 · Completed: Apr 1, 2027
1 condition
1 sponsor
1 location
NCT04611581
Objective Assessment of Behavioural Disorders in PD
N/A
Active, not recruiting
45 participants
Started: Apr 1, 2021 · Completed: Dec 31, 2025
2 conditions
3 sponsors
1 location
NCT04432025
Medication Following Bariatric Surgery for Type 2 Diabetes Mellitus
NA
Recruiting
150 participants
Started: Apr 1, 2021 · Completed: Aug 1, 2027
2 conditions
1 sponsor
1 location
NCT04803539
A Prospective, Phase II Trial Using ctDNA to Initiate Post-operation Boost Therapy After Adjuvant Chemotherapy in TNBC
PHASE2/PHASE3
Recruiting
260 participants
Started: Apr 1, 2021 · Completed: Sep 1, 2033
1 condition
2 sponsors
1 location
NCT04683315
PurIST Classification-Guided Adaptive Neoadjuvant Chemotherapy by RNA Expression Profiling of EUS Aspiration Samples
PHASE2
Recruiting
87 participants
Started: Apr 1, 2021 · Completed: Jun 30, 2027
1 condition
1 sponsor
2 locations
NCT05060848
Plasma Hydrogen Sulfide as a Biomarker for Alzheimer's Disease and Related Dementias
N/A
Active, not recruiting
100 participants
Started: Apr 1, 2021 · Completed: May 31, 2027
2 conditions
1 sponsor
1 location
NCT04978844
A Brief Emotion Focused Therapy for Preschoolers With Anxiety Disorders
NA
Recruiting
40 participants
Started: Apr 1, 2021 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT05062421
Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.
N/A
Recruiting
540 participants
Started: Apr 1, 2021 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT04817956
Improving Public Cancer Care by Implementing Precision Medicine in Norway
PHASE2
Recruiting
3,000 participants
Started: Apr 1, 2021 · Completed: Apr 30, 2045
1 condition
18 sponsors
17 locations
NCT04762641
This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors
PHASE1
Recruiting
100 participants
Started: Apr 1, 2021 · Completed: Jun 15, 2026
1 condition
1 sponsor
8 locations
NCT04597411
Study of 225Ac-PSMA-617 in Men With PSMA-positive Prostate Cancer
PHASE1
Recruiting
99 participants
Started: Apr 1, 2021 · Completed: Jan 1, 2027
1 condition
1 sponsor
2 locations
NCT04804956
Mesorectal Microbiome as a Prognostic Factor in Patients With Rectal Cancer
N/A
Recruiting
100 participants
Started: Apr 1, 2021 · Completed: Apr 1, 2026
1 condition
2 sponsors
1 location
Previous
1
More pages
1939
1940
1941
1942
1943
1944
1945
More pages
2369
Next